Trial intelligence / Profile preview

Vitamin B1 and duloxetine versus gabapentin for control of diabetic neuropathy pain

IRCT20111009007745N11Phase 3Completed

Sponsor
Yasouj University of Medical Sciences
Start
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of thiamine, duloxetine and gabapentin in diabetic neuropathy and diabetic polyneuropathy (DPN) (2 arms), sponsored by Yasouj University of Medical Sciences. Started Dec 2023; status: completed.

02

Drugs

thiamineduloxetinegabapentin
03

Conditions

diabetic neuropathydiabetic polyneuropathy (DPN)

Beyond the preview

Go deeper on IRCT20111009007745N11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20111009007745N11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call